Anixa Biosciences Inc (ANIX)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$3.07+0.66%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · ANIX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 | Oct 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | — | — | 0.2 | 0.2 | — | 0.5 | — |
| Total Revenues | — | — | 0.2 | 0.2 | — | 0.5 | — |
| Operating Expenses & Income | |||||||
| R&D Expenses | 4.6 | 5.1 | 6.4 | 4.8 | 6.7 | 6.2 | 4.4 |
| Operating Income | (10.7) | (11.7) | (13.8) | (11.0) | (13.9) | (13.1) | (10.0) |
| Net Income | |||||||
| Minority Interest | (0.1) | (0.1) | (0.1) | (0.1) | (0.2) | (0.2) | (0.1) |
| Net Income | (10.0) | (10.9) | (12.6) | (9.8) | (13.6) | (13.0) | (10.0) |
| Per Share | |||||||
| Basic EPS | (0.30) | (0.34) | (0.39) | (0.32) | 0.45 | (0.45) | — |
| Diluted EPS | (0.30) | (0.34) | (0.39) | (0.32) | 0.45 | — | — |
| Basic Weighted Avg Shares | 33.6 | 0.0 | 0.0 | 0.0 | 0.0 | — | — |
| Diluted Weighted Avg Shares | 33.6 | 0.0 | 0.0 | 0.0 | 0.0 | 28.6 | — |
| Supplemental | |||||||
| EBIT | (10.7) | (11.7) | (13.8) | (11.0) | (13.9) | (13.1) | (10.0) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.